ACR Convergence 2022

November 10-14, 2022. Philadelphia, PA.

View by Number View by Title View Sessions

View by Date

Sunday, November 13, 2022

8:00AM-9:00AM: Abstract Number: 0572

ACR Workgroup to Develop Recommendations for PRO Use in Clinical Care for SLE

Abstracts: Measures and Measurement of Healthcare Quality

8:00AM-9:00AM: Abstract Number: 0577

Bone Mineral Density of Radius 1/3 Led to a Better Fracture Prediction When Combined with Spine but Not Hip BMD: Results from the São Paulo Ageing & Health (SPAH) Study

Abstracts: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science

8:00AM-9:00AM: Abstract Number: 0561

CD8 T-Cell Expansion May Compensate for Natural Killer Cell Dysfunction in Mice with Chronic Excess IL-18

Abstracts: Cytokines and Cell Trafficking

8:00AM-9:00AM: Abstract Number: 0570

Clarifying Misbeliefs About Hydroxychloroquine (HCQ): Developing an Evidence-Based HCQ Benefits vs. Risk Decision Aid (HCQ-SAFE) Per Low Health Literacy Standards

Abstracts: Measures and Measurement of Healthcare Quality

8:00AM-9:00AM: Abstract Number: 0576

Comparative Effectiveness of Osteoporosis (OP) Therapies Among a Population of Postmenopausal (PM) Women in the United States (U.S.)

Abstracts: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science

8:00AM-9:00AM: Abstract Number: 0569

Cytokine Storm Susceptibility Factors IL-18 and Cytotoxic Impairment Converge on Pathologic CD8 T-cell Hyperactivation

Abstracts: Pediatric Rheumatology – Basic Science

8:00AM-9:00AM: Abstract Number: 0565

Deciphering Complement System-dependent Cellular Pathways in Human Rheumatoid Arthritis Synovial Tissues Using Single-cell Computational Omics

Abstracts: Genetics, Genomics and Proteomics

8:00AM-9:00AM: Abstract Number: 0567

Gain-of-Function Mutations in Lyn Kinase Cause a Novel Autoinflammatory Disease with Small Vessel Vasculitis and Liver Fibrosis

Abstracts: Pediatric Rheumatology – Basic Science

8:00AM-9:00AM: Abstract Number: 0563

High-Dimensional Immunophenotyping with Mass Cytometry Reveals Unique Immune Cell Aberrations in Patients with Undiagnosed Inflammatory and Autoimmune Diseases

Abstracts: Genetics, Genomics and Proteomics

8:00AM-9:00AM: Abstract Number: 0564

Identifying Shared Genetic Architecture Between RA and Other Conditions: A Phenome-Wide Association Study

Abstracts: Genetics, Genomics and Proteomics

8:00AM-9:00AM: Abstract Number: 0560

IL-17 Regulates Apolipoprotein E in Lymph Node Stromal Cells During Infection and Autoimmunity

Abstracts: Cytokines and Cell Trafficking

8:00AM-9:00AM: Abstract Number: 0559

JAK Inhibitor Withdrawal Causes a Transient Proinflammatory Signaling Cascade in Minor Salivary Gland Mesenchymal Stromal Cells

Abstracts: Cytokines and Cell Trafficking

8:00AM-9:00AM: Abstract Number: 0562

Large-Scale Targeted Sequencing Study Links Systemic Juvenile Idiopathic Arthritis with Rare Variants of MEFV, LYST, STXBP2, UNC13D

Abstracts: Genetics, Genomics and Proteomics

8:00AM-9:00AM: Abstract Number: 0558

Molecular Interplay Between Mammalian Target of Rapamycin (mTOR) and the YAP Pathway Mediates Rheumatoid Arthritis Synovial Fibroblast Activation

Abstracts: Cytokines and Cell Trafficking

8:00AM-9:00AM: Abstract Number: 0575

Myocardial Infarction and Stroke Risks Among Patients Who Initiated Treatment with Denosumab or Zoledronic Acid for Osteoporosis

Abstracts: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science

1
2
3
…
71
Next Page»

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].